-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Silo Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
- Silo Pharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1M, a 10.1% increase year-over-year.
- Silo Pharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$3.82M, a 15.6% increase year-over-year.
- Silo Pharma, Inc. annual Operating Income (Loss) for 2023 was -$3.86M, a 6.28% decline from 2022.
- Silo Pharma, Inc. annual Operating Income (Loss) for 2022 was -$3.63M, a 32.2% decline from 2021.
- Silo Pharma, Inc. annual Operating Income (Loss) for 2021 was -$2.74M, a 24.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)